request Request a Protocol
ask Ask a question
Favorite

A mixture of the appropriate 2-chloropyridine 1 (5 mmol), PdCl2(PPh3)2 (0.17 g; 5 mol-%), and Et3N (1.01 g; 10 mmol) was suspended in anhydrous THF (20 mL). The appropriate acetylene (5.5 mmol) was then injected under argon, followed by addition of CuI (0.02 g; 2.5 mol-%). The reaction mixture was stirred under argon at 40 °C temperature until full completion (1–3 h, completion observed by TLC). Solvent was evaporated under the reduced pressure; the crude residue was purified by column chromatography (elution by chloroform).

3,5-Dinitro-2-(phenylethynyl)pyridine (2a). 72%. Orange powder. M.p. 183–185 °C. 1H NMR (300 MHz, CDCl3): δ 7.45–7.54 (m, 3H, Ph.), 7.74–7.76 (d, J = 7.2 Hz, 2H, Ph), 9.17 (s, 1H, H4), 9.63 (s, 1H, H6). 13C NMR (75 MHz, DMSO-d6): δ 85.1, 100.9, 119.9, 128.7, 129.2, 131.3, 132.4, 142.3, 146.2, 148.3. HRMS (ESI) calc. for [C13H8N3O4]+ [M + H]+ 270.0509, found 270.0514.

3,5-Dinitro-2-(p-tolylethynyl)pyridine (2b). 63%. Orange powder. M.p. 203–205 °C. 1H NMR (300 MHz, CDCl3): δ 2.46 (s, 3H, Me), 7.30 (d, J = 8.0 Hz, 2H, p-Tolyl), 7.66 (d, J = 8.0 Hz, 2H, p-Tolyl), 9.18 (d, J = 2.2 Hz, 1H, H4), 9.63 (d, J = 2.2 Hz, 1H, H6). 13C NMR (75 MHz, DMSO-d6): δ 21.3, 84.9, 101.6, 116.8, 128.6, 129.8, 132.4, 139.8, 141.7, 142.1, 146.0, 148.3. HRMS (ESI) calc. for [C14H10N3O4]+ [M + H]+ 284.0666, found 284.0669.

3,5-Dinitro-2-((4-fluorophenyl)ethynyl)pyridine (2c). 61%. Orange powder. M.p. 170–172 °C. 1H NMR (200 MHz, DMSO-d6): δ 7.40 (t, J = 8.5 Hz, 2H, 4F-Ph), 7.78 (dd, J = 7.9, 5.7 Hz, 2H, 4F-Ph), 9.21 (d, J = 2.2 Hz, 1H, H4), 9.65 (d, J = 2.2 Hz, 1H, H6). 13C NMR (75 MHz, DMSO-d6): δ 85.0, 99.8, 128.8, 116.7 (d, 2JC–F = 22.5 Hz), 116.6, 116.0, 130.6, 135.2 (d, 3JC–F = 9.2 Hz), 139.6, 142.3, 146.1, 147.2, 148.4, 163.5 (d, 1JC–F = 251.5 Hz). HRMS (ESI) calc. for [C13H7FN3O4]+ [M + H]+ 288.0415, found 288.0417.

2-(Cyclopropylethynyl)-3,5-dinitropyridine (2d). 84%. Orange powder. M.p. 128–130 °C. 1H NMR (300 MHz, CDCl3): δ 1.09–1.18 (m, 4H), 1.68 (dt, J = 13.1, 6.6 Hz, 1H), 9.08 (d, J = 2.1 Hz, 1H, H4), 9.53 (d, J = 2.1 Hz, 1H, H6). 13C NMR (75 MHz, DMSO-d6): δ 0.4, 9.9, 72.1, 109.5, 128.4, 141.7, 148.0. HRMS (ESI) calc. for [C10H8N3O4]+ [M + H]+ 234.0509, found 234.0517.

2-(Cyclopentylethynyl)-3,5-dinitropyridine (2e). 32%. Orange oil. 1H NMR (300 MHz, CDCl3): δ 1.75–1.64 (m, 2H), 1.87 (m, 4H), 2.10 (m, 2H), 3.04 (p, J = 7.2 Hz, 1H), 9.08 (d, J = 2.1 Hz, 1H, H4), 9.55 (d, J = 2.1 Hz, 1H, H6). 13C NMR (75 MHz, CDCl3): δ 25.3, 31.2, 33.2, 76.5, 112.5, 127.9, 141.3, 142.0, 146.1, 147.7. HRMS (ESI) calc. for [C12H12N3O4]+ [M + H]+ 262.0822, found 262.0816.

2-(Hept-1-yn-1-yl)-3,5-dinitropyridine (2f). 35%. Orange oil. 1H NMR (300 MHz, CDCl3): δ 0.78–1.06 (m, 3H), 1.25–1.55 (m, 4H), 1.74 (p, J = 7.0 Hz, 2H), 2.63 (t, J = 7.1 Hz, 2H), 9.08 (d, J = 2.1 Hz, 1H, H4), 9.56 (d, J = 2.1 Hz, 1H, H6). 13C NMR (75 MHz, CDCl3): δ 14.0, 20.4, 22.3, 27.5, 31.2, 108.8, 112.6, 128.0, 128.4, 141.5, 142.2, 147.8 HRMS (ESI) calc. for [C12H14N3O4]+ [M + H]+ 264.0979, found 264.0970.

Methyl-5-nitro-6-(phenylethynyl)nicotinate (2g) 76%. Orange powder. M.p. 117–119 °C. 1H NMR (300 MHz, CDCl3): δ 4.05 (s, 3H, Me), 7.42–7.52 (m, 3H, Ph.), 7.71–7.74 (d, J = 7.2 Hz, 2H, Ph), 8.95 (d, J = 1,3 Hz, 1H, H4), 9.39 (d, J = 1.3 Hz, 1H, H6). 13C NMR (75 MHz, CDCl3): δ 53.2, 85.4, 101.4, 121.0, 125.0, 128.7, 130.7, 133.0, 133.5, 140.5, 146.5, 153.9, 163.5. HRMS (ESI) calc. for [C15H11N2O4]+ [M + H]+ 283.0713, found 283.0721.

3-Nitro-2-(phenylethynyl)-5-(trifluoromethyl)pyridine (2h) 42% Yellow powder. M.p. 124–126 °C. 1H NMR (300 MHz, CDCl3): δ 7.47 (m, 3H, Ph), 7.73 (d, J = 6.5 Hz, 2H, Ph), 8.65 (s, 1H, H4), 9.09 (s, 1H, H6). 13C NMR (126 MHz, CDCl3): δ 84.8, 101.5, 120.9, 124.4 (q, 1JC–F = 273.0 Hz), 125.8, 128.8, 130.4 (q, 3JC–F = 3.7 Hz), 131.0, 133.1, 140.6, 146.1, 149.9 (q, 3JC–F = 3.5 Hz). HRMS (ESI) calc. for [C14H8F3N2O2]+ [M + H]+ 293.0532, found 293.0542.

5-Chloro-3-nitro-2-(phenylethynyl)pyridine (2i) 40%. M.p. 103–105 °C. 1H NMR (300 MHz, CDCl3): δ 7.41–7.48 (m, 3H, Ph.), 7.69–7.71 (d, J = 6.8 Hz, 2H, Ph), 8.41 (d, J = 1.6 Hz, 1H, H4), 8.81 (d, J = 1.6 Hz, 1H, H6). 13C NMR (75 MHz, CDCl3): δ 84.5, 99.3, 121.3, 128.7, 130.4, 130.9, 132.3, 132.8, 135.5, 152.7. HRMS (ESI) calc. for [C13H8ClN2O2]+ [M + H]+ 259.0269, found 259.0259.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A